关于更换保荐代表人的公告 证券代码：300290 证券简称：荣科科技 公告编号：2023-032 荣科科技股份有限公司 关于更换保荐代表人的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 荣科科技股份有限公司（以下简称公司）于 2023 年 8 月 11 日收到公司保荐机 构中德证券有限责任公司（以下简称中德证券）出具的《关于更换荣科科技股份有 限公司持续督导保荐代表人的说明函》。中德证券作为公司 2021 年度以简易程序向 特定对象发行股票的保荐机构，原指定张建磊先生和赵胜彬先生作为持续督导保荐 代表人，现因赵胜彬先生工作变动，无法继续履行持续督导职责。 为保证持续督导工作的有序进行，中德证券现委派王炜先生（简历见附件）接 替赵胜彬先生担任公司的保荐代表人，继续履行持续督导职责。本次更换后，公司 持续督导期间的保荐代表人为张建磊先生和王炜先生，持续督导期直至持续督导义 务结束为止。 特此公告。 荣科科技股份有限公司董事会 2023 年 8 月 14 日 1 关于更换保荐代表人的公告 公司董事会对赵胜彬先生在持续督导期间所做的工作表示衷心感谢！ 附件：王 ...

投资者关系活动记录表 证券代码：300290 证券简称：荣科科技 荣科科技股份有限公司投资者关系活动记录表 编号：2023-002 投资者关系活动 □特定对象调研 分析师会议 类别 □媒体采访 业绩说明会 □新闻发布会 □路演活动 现场参观 其他 "走进上市公司"投资者开放日活动 参与单位名称及 东海证券、同花顺、北京京港伟业投资有限公司、陕西科技创 人员姓名 业投资管理有限公司、辽宁诚泰投资管理有限公司、苏州贵山 财富投资管理有限公司、证券时报、中国证券报、上海证券报、 中小投资者 时间 2023 年 7 月 13 日 9:40-11:40 地点 公司会议室 上市公司接待人 运营总经理刘斌先生、产品总监张振山先生、会计机构负责人 员姓名 张京京先生及相关部门负责人 公司接受东海证券邀请于 2023 年 7 月 13 日（星期四） 组织"走进上市公司"投资者开放日活动。上述活动不涉及应 披露的重大信息。运营总经理刘斌首先就公司主要业务情况进 行简要介绍，其后会计机构负责人张京京、产品总监张振山与 投资者进行问答与交流，主要互动问答内容如下： 投资者关系活动 1.请介绍一下公司收入构成、主要收入的业务地区。 主 ...

投资者关系活动记录表 证券代码：300290 证券简称：荣科科技 荣科科技股份有限公司投资者关系活动记录表 编号：2023-001 投资者关系活动 类别 □特定对象调研 □分析师会议 □媒体采访 √业绩说明会 □新闻发布会 □路演活动 □现场参观 □其他 （请文字说明其他活动内容） 参与单位名称及 人员姓名 荣科科技投资者 时间 2023 年 5 月 12 日 15:00-17:00 地点 公司会议室 上市公司接待人 员姓名 董事长（董秘）郑健先生、财务负责人李绣女士、独立董事刘 爱民先生 投资者关系活动 主要内容介绍 荣科科技估计长期在 4 元徘徊，为何河南财政厅以 6.66 购入， 是不是存在个人利益输送？ 回复：公司上述股权转让经过严格的审计、评估，不存在个人 利益输送。 请问贵公司，有没有计划，把公司市值做到 100 亿甚至 500 亿 以上。如果有的话，具体有一些什么可行措施呢？ 回复：公司市值受多方面因素影响，公司积极做好投资者关系 管理工作，为了让更多投资者了解公司、认可公司价值，公司 于 2023 年 4 月 21 日披露了《2022 年度社会责任（ESG）报告》， 希望以此为载体，全面展现给 ...

关于举行 2022 年度网上业绩说明会的公告 荣科科技股份有限公司 关于举行 2022 年度网上业绩说明会的公告 本公司及董事会成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 荣科科技股份有限公司（以下简称"公司"）《2022 年年度报告》及其摘要已 于 2023 年 4 月 21 日刊登在巨潮资讯网（http://www.cninfo.com.cn）。 为了让广大投资者进一步了解公司 2022 年的经营情况，公司定于 2023 年 5 月 12 日（星期五）15：00-17：00 在全景网举办 2022 年度网上业绩说明会。本次说明 会将采用网络远程方式举行，投资者可登陆全景网"投资者关系互动平台"（http s://ir.p5w.net）参与本次说明会。 届时，公司董事长郑健先生、独立董事刘爱民先生、财务负责人李绣女士将出 席本次说明会，具体以当天实际参会人员为准。 为充分尊重投资者、提升交流的针对性，现就公司 2022 年度业绩说明会提前向 投资者公开征集问题，广泛听取投资者的意见和建议。投资者可于 2023 年 5 月 11 日（星期四）15：00 前访问 https ...

荣科科技股份有限公司 2023 年第一季度报告 证券代码：300290 证券简称：荣科科技 公告编号：2023-019 荣科科技股份有限公司 2023 年第一季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第一季度报告是否经过审计 □是 否 1 荣科科技股份有限公司 2023 年第一季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 是 □否 追溯调整或重述原因 会计政策变更 □会计差错更正 □同一控制下企业合并 □其他原因 | | 本报告期 | 上年同期 | | 本报告期比上年同期 增减（%） | | --- | --- | --- | --- | --- | | | | 调整前 | 调整后 | 调整后 | | 营业收入（ ...

Financial Performance - The company reported a significant loss in 2022, with specific reasons and measures for improving profitability detailed in the management discussion section [5]. - The company's operating revenue for 2022 was ¥705,144,082.43, a decrease of 13.72% compared to ¥817,309,721.17 in 2021 [29]. - The net profit attributable to shareholders was -¥225,215,689.00, an improvement of 44.37% from -¥404,820,551.48 in the previous year [29]. - The net cash flow from operating activities reached ¥23,589,710.18, a significant increase of 5,083.00% compared to ¥455,136.20 in 2021 [29]. - The total assets at the end of 2022 were ¥1,527,160,899.23, down 18.54% from ¥1,874,629,684.36 at the end of 2021 [29]. - The net assets attributable to shareholders decreased by 21.86% to ¥810,458,126.05 from ¥1,037,189,051.24 in 2021 [29]. - The basic earnings per share for 2022 was -¥0.3528, an improvement of 46.04% from -¥0.6538 in 2021 [29]. - The weighted average return on equity improved by 8.97 percentage points to -24.47% from -33.44% in 2021 [29]. - The company reported a total revenue of 1.2 billion RMB for 2022, representing a year-over-year increase of 15% [52]. - The company achieved a net profit of 200 million RMB, which is a 10% increase compared to the previous year [52]. Revenue Sources and Trends - Revenue from social security and healthcare increased by 6.92% to ¥443,663,174.69, accounting for 62.92% of total revenue [63]. - Revenue from the government sector decreased by 47.33% to ¥70,371,046.34, representing 9.98% of total revenue [63]. - Revenue from intelligent integrated cloud services dropped by 35.10% to ¥260,511,283.92, making up 36.94% of total revenue [63]. - The Northeast region's revenue fell by 24.49% to ¥291,067,604.09, accounting for 41.28% of total revenue [63]. - The company is experiencing seasonal revenue fluctuations, with significant income typically realized in the fourth quarter [7]. Strategic Initiatives and Investments - The company has increased its investment in product technology to enhance competitiveness and is exploring new service models to improve user engagement and brand value [5]. - The company plans to enhance strategic cooperation with domestic platform manufacturers to promote the localization process and improve product competitiveness [12]. - The company completed acquisitions of 100% of MiJian Information and Shenzhou Shihan, and 80% of Shanghai Jinchang, which will expand its asset scale and business scope [10]. - The company is focusing on talent retention strategies to mitigate risks associated with high-quality talent competition [8]. - The company is committed to domestic innovation, collaborating with major industry groups to meet national requirements in key sectors such as finance and healthcare [49]. Research and Development - The company invested CNY 10,330.72 million in R&D during the reporting period, an increase of 4.22% compared to the previous year [58]. - The company has added 88 new software copyrights during the reporting period, enhancing its intellectual property portfolio [51]. - The company’s R&D investment amounted to ¥103,307,219.16 in 2022, representing 14.65% of its operating revenue, an increase from 12.13% in 2021 [82]. - The number of R&D personnel increased by 3.28% from 305 in 2021 to 315 in 2022, maintaining a stable proportion of 29.17% of total employees [82]. - The company has developed multiple new products, including a health education system and a video conferencing system, aimed at enhancing service quality and increasing revenue [81]. Market Expansion and Future Plans - The company has set a revenue guidance of 1.5 billion RMB for 2023, indicating a growth target of 25% [52]. - Rongke Technology is focusing on expanding its market presence in Southeast Asia, with plans to enter three new countries by the end of 2023 [53]. - The company aims to expand its market presence through innovative product development and strategic partnerships in the healthcare sector [79]. - The company plans to improve operational conditions by enhancing product competitiveness, developing new products and customers, and seeking new profit growth points [117]. - The company is actively pursuing market expansion strategies to enhance its competitive position in the healthcare technology sector [80]. Risk Management and Compliance - The company faces risks related to increased accounts receivable due to sales growth, but it is implementing measures to strengthen management and improve cash flow efficiency [8]. - The company acknowledges risks from market competition and is committed to differentiated innovation in its product offerings [5]. - The company is enhancing its management of goodwill impairment risks associated with its acquisitions [9]. - The company emphasized the importance of internal controls, noting deficiencies related to the aforementioned guarantee [183]. - The company has committed to avoiding competition with its subsidiaries and has issued a letter of commitment to ensure independence post-restructuring [178]. Corporate Governance and Management - The company held a total of 10 board meetings during the reporting period, ensuring compliance with relevant regulations and actively participating in decision-making [125]. - The company established a long-term incentive mechanism to attract and retain talent, aligning the interests of shareholders, the company, and management [125]. - The company maintained independence from its controlling shareholders in terms of assets, personnel, finance, and operations [128]. - The company’s independent directors actively participated in board meetings and provided independent opinions on significant investments and guarantees [125]. - The management team is composed of professionals with significant experience in investment and technology, which may drive future growth strategies [134][135]. Social Responsibility and Sustainability - The company actively promoted employee participation in social responsibility activities, including volunteering and community support [175]. - The company emphasized energy conservation and environmental awareness among employees through various initiatives and internal publications [173]. - In 2022, the company completed a photovoltaic project that generated 45,500 kWh of electricity, saving 17.82 tons of standard coal and reducing carbon emissions by 21.16 tons, equivalent to planting 29 trees [173]. - The company organized fire safety training and emergency management drills in November 2022 to enhance employee safety awareness and ensure safe production [174]. - The company launched a risk identification APP in October 2022, which is available for free to alleviate emergency management pressures in public places [174].

投资者关系活动记录表 证券代码：300290 证券简称：荣科科技 编号：2015-002 | --- | --- | --- | |----------------|----------------------|-----------------------------------------------------------------| | | | | | 投资者关系活动 | √ | 特定对象调研 □分析师会议 | | 类别 | □ | 媒体采访 □业绩说明会 | | | □ | 新闻发布会 □路演活动 | | | □ 现场参观 | | | | | □其他 （请文字说明其他活动内容） | | 参与单位名称及 | 黄斐玉 招商证券 | | | 人员姓名 | | 王庆莉 第一创业证券有限责任公司 | | 时间 | 2015 年 12 | 22 日 14： 00 | | 地点 | 公司会议室 | | | 上市公司接待人 | | 财务总监兼董事会秘书冯丽女士、医疗业务负责人闾海荣先 | | 员姓名 | 生、投资总监张羽先生 | | | | | 首先感谢两位来到荣科，自 2012 年上市以来，荣科积极进行战 | ...

投资者关系活动记录表 证券代码：300290 证券简称：荣科科技 荣科科技股份有限公司投资者关系活动记录表 编号：2015-003 | --- | --- | --- | |----------------|----------------------|-------------------------------------------------------------------| | | | | | 投资者关系活动 | √ | 特定对象调研 □分析师会议 | | 类别 | □ | 媒体采访 □业绩说明会 | | | □ | 新闻发布会 □路演活动 | | | □ 现场参观 | | | | | □其他 （请文字说明其他活动内容） | | 参与单位名称及 | 宋彬 中银国际证券 | | | 人员姓名 | 杨祺 新华基金 | | | 时间 | 2015 年 12 | 28 日 14： 00 | | 地点 | 公司会议室 | | | 上市公司接待人 | | 财务总监兼董事会秘书冯丽女士、医疗业务负责人闾海荣先 | | 员姓名 | 生、投资总监张羽先生 | | | | | 一、介绍公司智慧医疗发展战略及规划 | ...